Sangani Hospitals Limited — Important, 17-12-2024: Updates

**Financial Highlights:**

For the half-year ended September 30, 2024, Sangani Hospitals Limited reported revenue from operations of ₹1,000.84 Cr, a significant increase from ₹800.69 Cr in the previous fiscal year. Total revenue reached ₹1,076.82 Cr, up from ₹809.88 Cr year-over-year. The company achieved a profit before tax of ₹227.99 Cr, improving from ₹170.89 Cr. Net profit stood at ₹170.79 Cr, with earnings per share (EPS) increasing to ₹1.24 from ₹0.76.

**Strategic Initiatives and Growth Drivers:**

The company has effectively utilized IPO proceeds totaling ₹1,516.80 Cr, with ₹334.35 Cr already deployed, primarily for capital expenditures to expand its Keshod and Veraval hospitals.

**Business Developments:**

Sangani Hospitals recently completed an Initial Public Offering, which helped bolster its capital structure. The IPO was pivotal for financing growth initiatives, with plans for further capacity expansion in its healthcare services.

**Market Position and Competitive Advantage:**

Sangani Hospitals is carving out a competitive edge in the healthcare sector, aided by robust financial performance and strategic capital deployment. The company is well-positioned to capture a larger market share as it enhances its service offerings.

**Investor Implications:**

The strong financial metrics and strategic use of funds signal a positive outlook for Sangani Hospitals. Investors should watch the company closely for continued growth and performance improvements in the healthcare sector.